Over 95% of individuals with RTT present a mutation in the methyl-CpG-binding protein 2 (MECP2) gene, which is located at the end of the long arm of the X chromosome at site Xq28 [3,4,5]. This evidence concerns the gene MECP2 and Rett syndrome.